|
⚲
|
| Keyboard |
| Kishbauch Michael D
✚
|
|
|---|---|
| CIK # | 0001076979 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001076979] | |
| 4 | [0001076979] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Catabasis Pharmaceuticals Inc | |
| Kishbauch Michael D | |
| Achillion Pharmaceuticals Inc | |
| Progenics Pharmaceuticals Inc | |
| Tetralogic Pharmaceuticals Corp |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 14,100 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 26,550 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 8,333 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 16,666 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 14,100 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2025-06-11 | Grant | 26,550 | $0.00 | |
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2024-06-05 | Grant | 14,100 | $0.00 | |
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2023-06-02 | Grant | 14,100 | $0.00 | |
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (right to buy) · derivative
|
2022-06-09 | Grant | 8,333 | $0.00 | |
|
Catabasis Pharmaceuticals Inc CATB
Stock Option (right to buy) · derivative
|
2021-06-02 | Grant | 100,000 | $0.00 | |
|
Catabasis Pharmaceuticals Inc CATB
Stock Option (right to buy) · derivative
|
2020-06-11 | Grant | 7,500 | $0.00 | |
|
Achillion Pharmaceuticals Inc ACHN
Stock Options (Right to buy) · derivative
|
2020-01-28 | Disposed to issuer | 6,250 | ||
|
Achillion Pharmaceuticals Inc ACHN
Stock Options (Right to buy) · derivative
|
2020-01-28 | Disposed to issuer | 30,000 | ||
|
Achillion Pharmaceuticals Inc ACHN
Stock Options (Right to buy) · derivative
|
2020-01-28 | Disposed to issuer | 30,000 | ||
|
Achillion Pharmaceuticals Inc ACHN
Stock Options (Right to buy) · derivative
|
2020-01-28 | Disposed to issuer | 30,000 | ||
|
Achillion Pharmaceuticals Inc ACHN
Stock Options (Right to buy) · derivative
|
2020-01-28 | Disposed to issuer | 42,000 | ||
|
Achillion Pharmaceuticals Inc ACHN
Stock Options (Right to buy) · derivative
|
2020-01-28 | Disposed to issuer | 25,000 | ||
|
Progenics Pharmaceuticals Inc PGNX
Non-Qualified Stock Option (Right to Buy) · derivative
|
2019-07-11 | Grant | 25,000 | $0.00 | |
|
Catabasis Pharmaceuticals Inc CATB
Stock Option (right to buy) · derivative
|
2019-06-04 | Grant | 7,500 | $0.00 | |
|
Achillion Pharmaceuticals Inc ACHN
Stock Option (Right to buy) · derivative
|
2019-01-23 | Grant | 42,000 | $0.00 | |
| showing 20 of 65 most recent transactions | |||||